Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications

Lupus

Volumn 11, Issue 8, 2002, Pages 508-513

  Badsha, H ^a   Kong, K O ^a   Lian, T Y ^a   Chan, S P ^a   Edwards, C J ^a   Chng, H H ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Infection; Lupus erythematosus, systemic; Methylprednisolone; Mortality; Serum albumin

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; AZATHIOPRINE; CYCLOSPORIN; SERUM ALBUMIN;

ADULT; ARTICLE; DRUG COMBINATION; DRUG PULSE THERAPY; FEMALE; HUMAN; INCIDENCE; INFECTION; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; HOSPITAL ADMISSION; INFECTION PREVENTION; LEUKOPENIA; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; NEPHRITIS; NEUROPSYCHIATRY; PRIORITY JOURNAL; SEPTICEMIA; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADULT; ANTI-INFLAMMATORY AGENTS; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PULSE THERAPY, DRUG; RETROSPECTIVE STUDIES; RISK FACTORS; ANTI-INFLAMMATORY AGENTS, STEROIDAL; HUMAN; MIDDLE AGE;

EID: 0036024626     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203302lu243oa     Document Type: Article

References (30)

1. Systemic lupus erythematosus - Survival patterns. Experience with 609 patients
2. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death
3. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus
4. A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment
5. A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus
6. Double blind trial of pulse methylprednisolone versus conventional oral prednisolone in lupus nephritis
7. Risk factors for infection in Malaysian patients with systemic lupus erythematosus
8. Methylprednisolone in systemic lupus erythematosus
9. The 1982 revised criteria for the classification of systemic lupus erythematosus
10. The direct costs of a flare in systemic lupus erythematosus (SLE)
11. Improvement of the maintenance therapy after methylprednisolone pulse therapy - Effect of prednisolone combined with immunosuppressants
12. Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients
13. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: A prospective study of the Hopkins Lupus Cohort
14. Incidence of infection in systemic lupus erythematosus
15. Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in black Caribbean patients
16. Treatment of lupus nephritis
17. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial
18. Infections in systemic lupus erythematosus
19. Infections and immunosuppressive agents in rheumatology
20. Effect of corticosteroids on the human immune response: Comparison of one and three daily 1 gm intravenous pulses of methylprednisolone
21. Effect of high-dose methylprednisolone therapy on phagocyte function in systemic lupus erythematosus
22. Lymphocyte subpopulation alterations induced by intravenous megadose pulse methylprednisolone
23. Infections in 96 cases of systemic lupus erythematosus
24. Mortality of Jamaican patients with systemic lupus erythematosus
25. Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability
26. Adrenocorticosteroids and corticosteroid binding globulins in protein calorie malnutrition
27. Pharmacokinetics of prednisolone in children with the nephrotic syndrome
28. Prednisone side-effects and serum-protein levels. A collaborative study
29. Pharmacokinetic interaction between endogenous cortisol and exogenous corticosteroids